Bridgefront Capital’s Accendra Health ACH Stock Holding History

Bridgefront Capital’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29,304	Closed	-$265K	–	781
2025 Q1	$265K	Buy	+29,304	New	+$309K	0.08%	432

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bridgefront Capital's ACH Position: Q2 2025 in Review

Bridgefront Capital sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 29,304 shares — an estimated $265K sold.

Bridgefront Capital first reported a position in ACH in Q1 2025 and held it in 1 quarter. The position peaked at $265K in Q1 2025. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

Bridgefront Capital reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
Bridgefront Capital sold 29,304 Accendra Health shares in Q2 2025, an estimated $265K.
Bridgefront Capital first reported a position in Accendra Health in Q1 2025 and held it in 1 quarter.
Bridgefront Capital's Accendra Health position peaked at $265K in Q1 2025.
234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Bridgefront Capital's 13F filing for Q2 2025, filed 14 Aug 2025.